Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China

CONCLUSION: High-dose 60 μg hepatitis B vaccine could lead a satisfactory long-term durability of immunogenicity among patients with hemodialysis duration of five years or more. Peak anti-HBs level after vaccination was associated with the long-term persistence of immunogenicity.PMID:33814231 | DOI:10.1016/j.vaccine.2021.03.074

Source: Vaccine - April 5, 2021 Category: Allergy & Immunology Authors: Tian Yao Zhihong Shao Lina Wu Shuang Dong Linying Gao Yuanting Wu Xiaohong Shi Jing Shi Guangming Liu Jianmin Wang Huilin Zhao Hongping Guo Hongting Liu Xiaofeng Wu Liming Liu Xiaohui Song Jiangtao Zhu Yawei Zhang Yongliang Feng Xiaofeng Liang Suping Wang Source Type: research